Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer

Abstract Background It has been reported that pathological complete response is an important surrogate marker for disease-free survival and overall survival in patients with triple-negative breast cancer. This study investigates predictors of the response to neoadjuvant platinum-based or anthracycli...

Full description

Bibliographic Details
Main Authors: Paul Gass, Michael P. Lux, Claudia Rauh, Alexander Hein, Mayada R. Bani, Cornelia Fiessler, Arndt Hartmann, Lothar Häberle, Jutta Pretscher, Ramona Erber, David L. Wachter, Rüdiger Schulz-Wendtland, Matthias W. Beckmann, Peter A. Fasching, Marius Wunderle
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
Triple-negative breast cancer
Neoadjuvant therapy
Platinum
Pathological complete response
Prognosis
Prediction
Online Access:http://link.springer.com/article/10.1186/s12885-018-4925-1

Internet

http://link.springer.com/article/10.1186/s12885-018-4925-1

Similar Items